-
Why Johnson & Johnson Shares Are Trading Higher Today
Tuesday, October 19, 2021 - 11:13am | 220Johnson & Johnson (NYSE: JNJ) is trading higher Tuesday after the company announced better-than-expected third-quarter earnings results and raised guidance. Johnson & Johnson reported quarterly adjusted earnings of $2.60 per share, which beat the estimate of $2.36 per share. The...
-
5 Things You Might Not Know About New Johnson & Johnson CEO Joaquin Duato
Thursday, August 26, 2021 - 10:36am | 689Johnson & Johnson (NYSE: JNJ) announced recently a change in leadership with Alex Gorsky stepping down from his CEO role and handing the reigns to Joaquin Duato, who will take over on Jan. 3, 2022. Here are five things you might not know about Joaquin Duato, the next CEO of Johnson...
-
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
Sunday, August 22, 2021 - 9:01am | 840Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues, clinical readouts and regulatory actions that moved stocks during the week. Virpax Pharmaceuticals, Inc.(NASDAQ: VRPX)...
-
Jury Upholds $4.69B Verdict In Johnson & Johnson Baby Powder Case
Wednesday, December 19, 2018 - 2:49pm | 391A jury ruled against Johnson & Johnson (NYSE: JNJ) in which the health care giant attempted to reverse $4.14 billion in punitive damages and $550 million in compensatory damages. Shares of the Dow Jones component were trading lower Wednesday afternoon. What Happened Judge Rex Burlison of the...
-
Johnson & Johnson CEO Tells Cramer 'Thousands Of Studies' Refute Asbestos Allegations
Tuesday, December 18, 2018 - 9:45am | 491Several Johnson & Johnson (NYSE: JNJ) executives, mine managers, scientists, doctors and lawyers were aware that small amounts of asbestos were found in its baby powder -- a claim Johnson & Johnson CEO Alex Gorsky told CNBC's Jim Cramer is not true. What Happened Johnson & Johnson...
-
Jim Cramer Weighs In On Johnson & Johnson, Ford And More
Thursday, September 28, 2017 - 8:24am | 347On CNBC's "Mad Money Lightning Round," Jim Cramer said Johnson & Johnson (NYSE: JNJ) has the best balance sheet in the world. He has a lot of faith in CEO Alex Gorsky. Cramer added that he would buy a half of the position on Thursday, and he would buy more if it drops to $125. Cramer thinks...
-
Johnson & Johnson Management Meetings Leave UBS Reiterating Stock As A Top Pick
Thursday, August 31, 2017 - 12:28pm | 239After spending the day with Johnson & Johnson (NYSE: JNJ) CEO Alex Gorsky, UBS analysts have reiterated a Buy on the company and called the stock one of the bank's top picks. “We came away from our day of meetings with JNJ Chairman and CEO Alex Gorsky with greater conviction in our...
-
A CEO Who's Who Of Trump's Manufacturing Council
Friday, January 27, 2017 - 5:36pm | 2282A group of more than two dozen CEOs have been tapped by President Donald Trump to create recommendations to grow the American manufacturing sector. The group convenes at a time when Trump is pledging to cut corporate taxes, slash regulations and also heavily tax companies that outsource...
-
9 Of The Most Successful Veterans Turned CEOs
Friday, November 11, 2016 - 12:00pm | 714Veterans are known for their discipline, efficiency and crisis management. Therefore, it logically follows that corporations give them top posts, incorporating those qualities in their organizations and business models. Another key reason for hiring veterans for CEO positions is they tend to make...
-
Johnson & Johnson Earnings Recap: Beats Estimates By Four Cents
Tuesday, January 21, 2014 - 3:49pm | 325On Tuesday morning, Johnson & Johnson (NYSE: JNJ) reported its fourth quarter results. The company announced an EPS of $1.24, beating the consensus estimate by four cents. Revenue of $18.40 billion came in $450 million higher than the consensus estimate. The company benefited from domestic...
-
Goldman Sachs Comments on Breaking Up of Johnson & Johnson
Thursday, May 31, 2012 - 6:37am | 195Goldman Sachs has published a research report on Johnson & Johnson (NYSE: JNJ) commenting on the company's break up and new CEO Alex Gorsky. In the report, Goldman Sachs writes, "There are several strategies through which we think new CEO Alex Gorsky can generate higher returns for JNJ;...